# Astellas Pharma Inc. (ALPMY)

> Healthcare · JP · Reports in JPY

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ALPMY/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | ¥ 1,296.84B | ¥ 201.51B | ¥ 267.01B | ¥ 585.98B | ¥ 1,929.86B |
| 2025 | ¥ 2,080.07B | ¥ 326.05B | ¥ 416.42B | ¥ 725.77B | ¥ 1,764.33B |
| 2024 | ¥ 1,867.63B | ¥ -57.43B | ¥ 120.76B | ¥ 915.36B | ¥ 1,493.81B |
| 2023 | ¥ 1,543.32B | ¥ 58.00M | ¥ 134.15B | ¥ 870.98B | ¥ 1,503.26B |
| 2022 | ¥ 1,468.24B | ¥ 136.43B | ¥ 185.32B | ¥ 148.74B | ¥ 1,570.42B |
| 2021 | ¥ 1,300.91B | ¥ 120.17B | ¥ 213.84B | ¥ 201.53B | ¥ 1,466.29B |
| 2020 | ¥ 1,244.49B | ¥ 137.34B | ¥ 242.05B | ¥ 1.25B | ¥ 1,368.61B |
| 2019 | ¥ 1,265.58B | ¥ 216.60B | ¥ 180.06B | ¥ 3.15B | ¥ 1,317.45B |
| 2018 | ¥ 1,291.60B | ¥ 211.26B | ¥ 277.69B | ¥ 1.57B | ¥ 1,292.21B |
| 2017 | ¥ 1,295.13B | ¥ 181.06B | ¥ 235.36B | ¥ 3.76B | ¥ 1,366.86B |
| 2016 | ¥ 1,315.41B | ¥ 208.38B | ¥ 300.08B | ¥ 842.00M | ¥ 1,313.55B |
| 2015 | ¥ 1,367.20B | ¥ 186.62B | ¥ 168.30B | ¥ 1.71B | ¥ 1,322.29B |
| 2014 | ¥ 1,214.00B | ¥ 125.05B | ¥ 143.17B | ¥ 90.00M | ¥ 1,374.19B |
| 2013 | ¥ 1,173.63B | ¥ 82.19B | ¥ 385.77M | ¥ 0 | ¥ 1,160.37B |
| 2012 | ¥ 536.49B | ¥ 51.50B | ¥ 0 | ¥ 0 | ¥ 1,051.23B |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.30 |
| Liabilities / Eq | 0.90 |
| Current Ratio | 1.20 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 3.70 |
| Gross Debt / FCF | 2.41 |

## Other views

- [Metrics](https://sponda.capital/en/ALPMY.md)
- [Charts](https://sponda.capital/en/ALPMY/charts.md)
- [Compare](https://sponda.capital/en/ALPMY/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.